Graf Akcie ADMP (Adamis Pharmaceuticals Corp). Diskuze k akciím ADMP. Aktuální informace ADMP.

Základní informace o společnosti Adamis Pharmaceuticals Corp (Akcie ADMP)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	159.31M
Hodnota podniku (EV)	153.25M
Tržby	16.527M
EBITDA	-33.62
Zisk	-49.39
Růst v tržbách Q/Q	-34.35 %
Růst v tržbách Y/Y	-25.26 %
P/E (Cena vůči ziskům)	N/A
Forward P/E	-0.03
EV/Sales	9.27
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	5.02
P/FCF	N/A
Price/Book	48.53
Účetní hodnota na akcii	0.02
Hotovost na akcii	0.05
FCF vůči ceně	-21.37 %
Počet zaměstnanců	130
Tržba na zaměstnance	127.134k
Profit margin	-298.84 %
Operating margin	-225.25 %
Gross margin	9.88 %
EBIT margin	-297.86 %
EBITDA margin	-203.43 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	200.00 %
EPS - Očekávaný růst příští rok	-60.00 %
Return on assets	-59.12 %
Return on equity	-270.65 %
ROIC	-125.09 %
ROCE	-449.92 %
Dluhy/Equity	7.83
Čistý dluh/EBITDA	0.39
Current ratio	0.63
Quick Ratio	0.40
Volatilita	5.28
Beta	1.18
RSI	62.84
Cílová cena analytiků	1
Známka akcie (dle analytiků)	3.00
Insider ownership	1.06 %
Institutional ownership	8.41 %
Počet akcií	148.886M
Procento shortovaných akcií	6.47 %
Short ratio	5.41 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2003
Země	United States

Finanční výsledky akcie ADMP

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$22.114	$15.087	$13.073	$6.474	-	-
Cost Of Goods Sold	$15.479	$9.798	$7.42	$4.854	-	-
Gross Profit	$6.635	$5.289	$5.653	$1.62	-	-
Research And Development Expenses	$10.376	$18.794	$7.527	$9.697	$4.843	$3.546
SG&A Expenses	$25.288	$25.948	$22.819	$17.128	$9.007	$4.556
Other Operating Income Or Expenses	$-0.322	$-0.011	$-0.096	-	-	-
Operating Expenses	$51.465	$54.55	$37.862	$31.678	$13.85	$8.102
Operating Income	$-29.351	$-39.464	$-24.789	$-25.204	$-13.85	$-8.102
Total Non-Operating Income/Expense	$0.053	$0.088	$-1.089	$1.192	$0.278	$-1.215
Pre-Tax Income	$-29.298	$-39.376	$-25.878	$-24.012	$-13.572	$-9.316
Income Taxes	$0.009	$-0.369	$-0.339	$-4.575	-	-
Income After Taxes	$-29.307	$-39.007	$-25.539	$-19.437	$-13.572	$-9.316
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-29.307	$-39.007	$-25.539	$-19.437	$-13.572	$-9.316
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-29.307	$-39.007	$-25.539	$-20.812	$-13.572	$-9.316
EBITDA	$-26.406	$-36.365	$-21.726	$-22.67	$-12.86	$-6.997
EBIT	$-29.351	$-39.464	$-24.789	$-25.204	$-13.85	$-8.102
Basic Shares Outstanding	53	39	28	18	13	11
Shares Outstanding	53	39	28	18	13	11
Basic EPS	$-0.55	$-1.00	$-0.90	$-1.19	$-1.02	$-0.89
EPS - Earnings Per Share	$-0.55	$-1.00	$-0.90	$-1.19	$-1.03	$-0.89

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$8.811	$19.272	$18.333	$5.096	$4.081	$3.775
Receivables	$1.878	$1.155	$0.83	$0.805	-	-
Inventory	$2.061	$3.279	$1.825	$0.942	-	-
Pre-Paid Expenses	$1.127	$2.078	$0.474	$0.227	$0.071	$0.18
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$13.877	$25.784	$21.462	$7.07	$4.152	$3.954
Property, Plant, And Equipment	$11.667	$9.868	$6.56	$4.897	-	$0.078
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	$18.768	$20.851	$23.327	$25.777	$7.767	$8.738
Other Long-Term Assets	$1.655	$1.855	$0.055	$0.043	$0.143	$0.128
Total Long-Term Assets	$33.964	$32.574	$29.942	$30.716	$7.91	$8.943
Total Assets	$47.841	$58.358	$51.403	$37.786	$12.062	$12.897
Total Current Liabilities	$10.21	$11.554	$8.788	$8.611	$2.748	$3.394
Long Term Debt	-	-	$2.583	$3.067	-	-
Other Non-Current Liabilities	-	-	-	-	-	-
Total Long Term Liabilities	$1.594	$0.113	$3.068	$3.896	-	-
Total Liabilities	$11.803	$11.666	$11.856	$12.507	$2.748	$3.394
Common Stock Net	$0.006	$0.005	$0.003	$0.002	$0.001	$0.001
Retained Earnings (Accumulated Deficit)	$-182.315	$-153.004	$-113.998	$-88.459	$-69.021	$-55.449
Comprehensive Income	-	-	-	-	-	-
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$36.037	$46.692	$39.548	$25.28	$9.314	$9.503
Total Liabilities And Share Holders Equity	$47.841	$58.358	$51.403	$37.786	$12.062	$12.897

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-29.307	$-39.007	$-25.539	$-19.437	$-13.572	$-9.316
Total Depreciation And Amortization - Cash Flow	$2.945	$3.099	$3.064	$2.535	$0.99	$1.105
Other Non-Cash Items	$7.093	$9.794	$8.364	$-1.108	$2.275	$1.511
Total Non-Cash Items	$10.038	$12.893	$11.428	$1.427	$3.265	$2.616
Change In Accounts Receivable	$-0.745	$-0.421	$-0.088	$-0.363	-	-
Change In Inventories	$0.025	$-4.98	$-2.404	$0.002	-	-
Change In Accounts Payable	$0.575	$0.846	$0.587	$-1.707	$-0.289	$0.116
Change In Assets/Liabilities	$0.856	$-2.408	$-0.287	$-0.093	$0.109	$-0.165
Total Change In Assets/Liabilities	$-0.616	$-6.544	$-1.021	$-3.15	$-0.029	$0.288
Cash Flow From Operating Activities	$-19.886	$-32.658	$-15.133	$-21.16	$-10.336	$-6.412
Net Change In Property, Plant, And Equipment	$-2.866	$-3.535	$-2.062	$-0.121	-	-
Net Change In Intangible Assets	-	-	$-0.026	-	-	-
Net Acquisitions/Divestitures	-	-	-	$0.382	-	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	-	-	-	-	-	-
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$-2.866	$-3.535	$-2.088	$0.261	-	-
Net Long-Term Debt	$-0.067	-	-	-	-	$-0.639
Net Current Debt	$-0.43	$-0.488	$-2.331	$1.675	-	-
Debt Issuance/Retirement Net - Total	$-0.497	$-0.488	$-2.331	$1.675	-	$-0.639
Net Common Equity Issued/Repurchased	$12.788	$37.62	$32.788	$10.394	$10.642	$0.493
Net Total Equity Issued/Repurchased	$12.788	$37.62	$32.788	$20.239	$10.642	$5.422
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	-	-	-	-	-	-
Cash Flow From Financial Activities	$12.291	$37.132	$30.458	$21.915	$10.642	$4.784
Net Cash Flow	$-10.461	$0.939	$13.237	$1.015	$0.306	$-1.629
Stock-Based Compensation	$5.868	$6.535	$6.058	$4.758	$2.511	$0.651
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	1.3592	2.2317	2.4423	0.8211	1.5109	1.165
Long-term Debt / Capital	-	-	0.0613	0.1082	-	-
Debt/Equity Ratio	0.0597	0.0553	0.1281	0.2926	-	-
Gross Margin	30.004	35.0552	43.243	25.0281	-	-
Operating Margin	-132.7249	-261.5808	-189.6167	-389.3182	-	-
EBIT Margin	-132.7249	-261.5808	-189.6167	-389.3182	-	-
EBITDA Margin	-119.4097	-241.04	-166.183	-350.1672	-	-
Pre-Tax Profit Margin	-132.4874	-260.9999	-197.9489	-370.9005	-	-
Net Profit Margin	-132.5266	-258.5518	-195.3528	-321.4636	-	-
Asset Turnover	0.4622	0.2585	0.2543	0.1713	-	-
Inventory Turnover Ratio	7.51	2.9881	4.0667	5.1521	-	-
Receiveable Turnover	11.7774	13.0602	15.7492	8.0385	-	-
Days Sales In Receivables	30.9916	27.9476	23.1758	45.4065	-	-
ROE - Return On Equity	-81.3236	-83.5409	-64.578	-76.8885	-145.7172	-98.0356
Return On Tangible Equity	-169.7068	-150.9515	-157.452	3912.495	-877.2691	-1217.277
ROA - Return On Assets	-61.2593	-66.8405	-49.6837	-51.4398	-112.52	-72.2354
ROI - Return On Investment	-81.3236	-83.5409	-60.6186	-68.5692	-145.7156	-98.0342
Book Value Per Share	0.5828	0.9873	1.1844	1.1495	0.6935	0.8922
Operating Cash Flow Per Share	0.4622	-0.3017	0.6753	-0.4399	-0.1601	0.2958
Free Cash Flow Per Share	0.4988	-0.3195	0.6095	-0.4468	-0.1601	0.3087

Premium

Tento článek patří k prémiovému obsahu našeho webu.

Již mám předplatné

Roční předplatné

Ušetříte 589 Kč oproti měsíčnímu předplatnému

2 999Kč

Objednat

Čtvrtletní předplatné

Ušetříte 98 Kč oproti měsíčnímu předplatnému

799Kč

Objednat

Měsíční předplatné

Předplatné našich prémiových služeb na měsíc.

299Kč

Objednat

Porovnání s konkurencí: Akcie ADMP

Společnost	P/E	PEG	Růst v tržbách (roční)	Růst v EPS	Return on equity	P/B	Profit margin
ADMP	N/A	N/A	-25.26 %	-60.00 %	-270.65 %	48.53	-298.84 %
Akcie ATRS	8.79	0.35	24.41 %	0.00 %	58.38 %	4.92	37.57 %
Akcie ATRS	8.79	0.35	24.41 %	0.00 %	58.38 %	4.92	37.57 %
Akcie ATRS	8.79	0.35	24.41 %	0.00 %	58.38 %	4.92	37.57 %
Akcie CORT	24.21	N/A	-2.31 %	17.65 %	19.08 %	4.42	29.96 %
Akcie CORT	24.21	N/A	-2.31 %	17.65 %	19.08 %	4.42	29.96 %
Akcie CORT	24.21	N/A	-2.31 %	17.65 %	19.08 %	4.42	29.96 %
Akcie EMIS	N/A	N/A	34.36 %	N/A %	N/A %	-3.06	-205.75 %
Akcie EMIS	N/A	N/A	34.36 %	N/A %	N/A %	-3.06	-205.75 %
Akcie EMIS	N/A	N/A	34.36 %	N/A %	N/A %	-3.06	-205.75 %
Akcie GSK	16.47	3.36	N/A %	-14.00 %	29.69 %	4.91	16.86 %
Akcie GSK	16.47	3.36	N/A %	-14.00 %	29.69 %	4.91	16.86 %
Akcie GSK	16.47	3.36	N/A %	-14.00 %	29.69 %	4.91	16.86 %
Akcie JNJ	23.88	1.67	10.79 %	7.27 %	27.01 %	6.71	17.82 %
Akcie JNJ	23.88	1.67	10.79 %	7.27 %	27.01 %	6.71	17.82 %
Akcie JNJ	23.88	1.67	10.79 %	7.27 %	27.01 %	6.71	17.82 %
Akcie MYL	32.42	0.68	1.11 %	-2.86 %	2.25 %	0.72	N/A %
Akcie MYL	32.42	0.68	1.11 %	-2.86 %	2.25 %	0.72	N/A %
Akcie MYL	32.42	0.68	1.11 %	-2.86 %	2.25 %	0.72	N/A %
Akcie PFE	17.66	1.97	4.96 %	50.00 %	19.81 %	3.72	22.95 %
Akcie PFE	17.66	1.97	4.96 %	50.00 %	19.81 %	3.72	22.95 %
Akcie PFE	17.66	1.97	4.96 %	50.00 %	19.81 %	3.72	22.95 %
Akcie SIGA	12.77	N/A	72.48 %	N/A %	36.26 %	4.13	45.09 %
Akcie SIGA	12.77	N/A	72.48 %	N/A %	36.26 %	4.13	45.09 %
Akcie SIGA	12.77	N/A	72.48 %	N/A %	36.26 %	4.13	45.09 %
Akcie SIGA	12.77	N/A	72.48 %	N/A %	36.26 %	4.13	45.09 %
Akcie SIGA	12.77	N/A	72.48 %	N/A %	36.26 %	4.13	45.09 %
Akcie SIGA	12.77	N/A	72.48 %	N/A %	36.26 %	4.13	45.09 %
Akcie TEVA	N/A	0.79	-0.96 %	12.07 %	-39.21 %	1.08	-23.95 %
Akcie TEVA	N/A	0.79	-0.96 %	12.07 %	-39.21 %	1.08	-23.95 %
Akcie TEVA	N/A	0.79	-0.96 %	12.07 %	-39.21 %	1.08	-23.95 %

Nedávné obchody insiderů: Akcie ADMP

Jméno	Obchod	Cena	Objem
David J. Marguglio SVP and Chief Business Officer	Prodej 18 Nov 2020	$0.41	$3,498
Karen K. Daniels VP of Operations	Prodej 18 Nov 2020	$0.41	$2,187
Dennis J Phd Carlo President and amp; CEO	Prodej 18 Nov 2020	$0.41	$4,373
Robert O Hopkins Chief Financial Officer	Prodej 18 Nov 2020	$0.41	$2,964
Ronald B. Moss Chief Medical Officer	Prodej 18 Nov 2020	$0.41	$3,498
Robert O Hopkins Chief Financial Officer	Prodej 20 Nov 2020	$0.41	$14,350
David J. Marguglio SVP and Chief Business Officer	Prodej 20 Nov 2020	$0.40	$14,000
Dennis J Phd Carlo President and amp; CEO	Option 21 Feb 2021	$1.38	$38,394
Ronald B. Moss Chief Medical Officer	Option 21 Feb 2021	$1.38	$19,197
David J. Marguglio SVP and Chief Business Officer	Option 21 Feb 2021	$1.38	$30,716
Robert O Hopkins Chief Financial Officer	Option 21 Feb 2021	$1.38	$30,716
David J. Marguglio SVP and Chief Business Officer	Prodej 18 Nov 2020	$0.41	$3,498
Karen K. Daniels VP of Operations	Prodej 18 Nov 2020	$0.41	$2,187
Dennis J Phd Carlo President and amp; CEO	Prodej 18 Nov 2020	$0.41	$4,373
Robert O Hopkins Chief Financial Officer	Prodej 18 Nov 2020	$0.41	$2,964
Ronald B. Moss Chief Medical Officer	Prodej 18 Nov 2020	$0.41	$3,498
Robert O Hopkins Chief Financial Officer	Prodej 20 Nov 2020	$0.41	$14,350
David J. Marguglio SVP and Chief Business Officer	Prodej 20 Nov 2020	$0.40	$14,000
Dennis J Phd Carlo President and amp; CEO	Option 21 Feb 2021	$1.38	$38,394
Ronald B. Moss Chief Medical Officer	Option 21 Feb 2021	$1.38	$19,197
David J. Marguglio SVP and Chief Business Officer	Option 21 Feb 2021	$1.38	$30,716
Robert O Hopkins Chief Financial Officer	Option 21 Feb 2021	$1.38	$30,716

JenAkcie

Graf Akcie ADMP (Adamis Pharmaceuticals Corp). Diskuze k akciím ADMP. Aktuální informace ADMP.

Základní informace o společnosti Adamis Pharmaceuticals Corp (Akcie ADMP)

Finanční výsledky akcie ADMP

Tento článek patří k prémiovému obsahu našeho webu.

Roční předplatné

Čtvrtletní předplatné

Měsíční předplatné

Porovnání s konkurencí: Akcie ADMP

Nedávné obchody insiderů: Akcie ADMP

Diskuze k akciím ADMP